Advisory Services Network’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-33
Closed -$303 3832
2023
Q1
$303 Hold
33
﹤0.01% 3805
2022
Q4
$391 Buy
+33
New +$582 ﹤0.01% 3773
2021
Q3
Sell
-33
Closed -$3K 3374
2021
Q2
$3K Buy
+33
New +$3.22K ﹤0.01% 3263
2021
Q1
Sell
-187
Closed -$15K 3070
2020
Q4
$15K Buy
187
+140
+298% +$11.9K ﹤0.01% 2266
2020
Q3
$4K Buy
+47
New +$5.48K ﹤0.01% 2885

Other funds holding VBIV

Advisory Services Network's VBIV Position: Q2 2023 in Review

Advisory Services Network sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q2 2023, closing a stake of 33 shares — an estimated $303 sold.

Advisory Services Network first reported a position in VBIV in Q3 2020 and held it in 5 quarters. The position peaked at $15K in Q4 2020. 46 funds tracked by Wall St. Rank hold VBIV as of Q2 2023.

  • Advisory Services Network reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q2 2023 after selling out during the quarter.
  • Advisory Services Network sold 33 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q2 2023, an estimated $303.
  • Advisory Services Network first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q3 2020 and held it in 5 quarters.
  • Advisory Services Network's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $15K in Q4 2020.
  • 46 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q2 2023.

Based on Advisory Services Network's 13F filing for Q2 2023, filed 9 Aug 2023.